Cargando…

Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences

BACKGROUND: For patients receiving daily opioid agonist treatment (OAT) for opioid dependence, several countries relaxed treatment guidelines at the beginning of the COVID-19 pandemic. This involved longer take-home intervals for methadone and buprenorphine doses as well as a reduction in supervised...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonald, Rebecca, Bech, Anne Berit, Clausen, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485985/ https://www.ncbi.nlm.nih.gov/pubmed/37679751 http://dx.doi.org/10.1186/s12913-023-09959-7

Ejemplares similares

Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
por: Bech, Anne Berit, et al.
Publicado: (2019)

Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway
por: Rolová, Gabriela, et al.
Publicado: (2023)

Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2020)

Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Unspecified opioids among opioid overdoses in Oslo, Norway
por: Iqbal, Zahra Zeineb, et al.
Publicado: (2022)

Improving recruitment to pharmacological trials for illicit opioid use: findings from a qualitative focus group study
por: Neale, Joanne, et al.
Publicado: (2018)

A qualitative study of the work experiences of midwives performing obstetric ultrasound in Norway
por: Reiso, Magnhild, et al.
Publicado: (2020)

Patients’ Perspectives on Coming Off Opioid Agonist Treatment: A Qualitative Study
por: Nehlin, Christina, et al.
Publicado: (2022)

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
por: Aas, Christer Frode, et al.
Publicado: (2020)

Quantitative proteomic analysis reveals the effects of mu opioid agonists on HT22 cells
por: Zhang, Xutong, et al.
Publicado: (2023)

Patient Satisfaction of General Dermatology Providers: A Quantitative and Qualitative Analysis of 38,008 Online Reviews
por: Queen, Dawn, et al.
Publicado: (2021)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Women’s experiences and views on early breastfeeding during the COVID-19 pandemic in Norway: quantitative and qualitative findings from the IMAgiNE EURO study
por: Vik, Eline Skirnisdottir, et al.
Publicado: (2023)

Scoping review protocol: the use of telemedicine in providing opioid agonist treatment and related psychosocial supports
por: Crowley, Des, et al.
Publicado: (2020)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway
por: Vold, Jørn Henrik, et al.
Publicado: (2022)

Analgesic tolerance of opioid agonists in mutant mu-opioid receptors expressed in sensory neurons following intrathecal plasmid gene delivery
por: Li, Guangwen, et al.
Publicado: (2013)

Opioid maintenance treatment in the Czech Republic, Norway and Denmark: a study protocol of a comparative registry linkage study
por: Gabrhelík, Roman, et al.
Publicado: (2021)

Marketed New Drug Delivery Systems for Opioid Agonists/Antagonists Administration: A Rapid Overview
por: Soltani, Hoda, et al.
Publicado: (2016)

Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans
por: Eydt, Erin, et al.
Publicado: (2021)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Attitudes towards sickness absence and sickness presenteeism in health and care sectors in Norway and Denmark: a qualitative study
por: Krane, Line, et al.
Publicado: (2014)

The four-factor personality model and its qualitative correlates among opioid agonist therapy clients
por: Mahu, Ioan T., et al.
Publicado: (2023)

Provider perspectives on contraceptive service delivery: findings from a qualitative study in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2020)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

Beyond challenges and enrichment: a qualitative account of cross-cultural experiences of nursing patients with an ethnic minority background in Norway
por: Alkhaled, Tariq, et al.
Publicado: (2022)

What are the challenges in the vaccination of migrants in Norway from healthcare provider perspectives? A qualitative, phenomenological study
por: Socha, Anna, et al.
Publicado: (2020)

Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms
por: Treitler, Peter C., et al.
Publicado: (2022)

Leveraging existing provider networks in Europe to eliminate barriers to accessing opioid agonist maintenance therapies for Ukrainian refugees
por: Nikitin, Benjamin M., et al.
Publicado: (2023)

Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user’s perspective
por: Ghaddar, Ali, et al.
Publicado: (2018)

Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment
por: Palis, Heather, et al.
Publicado: (2021)

Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study
por: Keller, Michelle S., et al.
Publicado: (2019)

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
por: Day, Nathaniel, et al.
Publicado: (2022)

Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

“You’re Not Supposed to be on it Forever”: Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids
por: Dickson-Gomez, Julia, et al.
Publicado: (2022)

Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study
por: Oviedo-Joekes, Eugenia, et al.
Publicado: (2023)

Maternal Health Coping Strategies of Migrant Women in Norway
por: Viken, Berit, et al.
Publicado: (2015)

Aspiring for competence in a multifaceted everyday life: A qualitative study of adult students’ experiences of a blended learning master programme in Norway
por: Gjestvang, Bodil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lic141lt8fufaolg9nsh1fphg5